Wemedoo wins 1st place at EthAum Healthcare Innovation Days

The program is run by EthAum Venture Partners, a deep-tech investor and revenue scaler that supports B2B startups in reaching enterprise customers, partners and investors globally. Its healthcare advisory board includes physicians, healthcare investors and senior industry leaders. This year’s jury evaluated innovations across a wide range of healthcare use cases and selected three standout companies for their impact and technology.

The jury recognized oomnia, Wemedoo’s clinical trial system, for bringing eight essential clinical trial tools together natively in one software, significantly reducing the cost and time needed to run a trial.

That recognition reflects what oomnia was built for. Instead of stitching together separate systems for EDC, RTSM, eTMF, eConsent and other trial functions, sponsors and CROs work in a single platform where every module is connected and data flows between them. oomnia was designed by clinical professionals to solve the problems they faced in real trials, and that clinical knowledge is part of every module.

We congratulate our fellow finalists, metaBIX Biotech and Staple AI, and thank EthAum Venture Partners and the jury for the recognition!